These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10593924)

  • 1. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.
    Yokosaki Y; Matsuura N; Sasaki T; Murakami I; Schneider H; Higashiyama S; Saitoh Y; Yamakido M; Taooka Y; Sheppard D
    J Biol Chem; 1999 Dec; 274(51):36328-34. PubMed ID: 10593924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL; Giachelli CM
    Exp Cell Res; 1998 Jul; 242(1):351-60. PubMed ID: 9665832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
    Bayless KJ; Davis GE
    J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit.
    Mould AP; Askari JA; Humphries MJ
    J Biol Chem; 2000 Jul; 275(27):20324-36. PubMed ID: 10764748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin.
    Marcinkiewicz C; Taooka Y; Yokosaki Y; Calvete JJ; Marcinkiewicz MM; Lobb RR; Niewiarowski S; Sheppard D
    J Biol Chem; 2000 Oct; 275(41):31930-7. PubMed ID: 10926928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins.
    Green PM; Ludbrook SB; Miller DD; Horgan CM; Barry ST
    FEBS Lett; 2001 Aug; 503(1):75-9. PubMed ID: 11513858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.
    Katagiri YU; Murakami M; Mori K; Iizuka J; Hara T; Tanaka K; Jia WY; Chambers AF; Uede T
    J Cell Biochem; 1996 Jul; 62(1):123-31. PubMed ID: 8836881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin.
    Yokosaki Y; Palmer EL; Prieto AL; Crossin KL; Bourdon MA; Pytela R; Sheppard D
    J Biol Chem; 1994 Oct; 269(43):26691-6. PubMed ID: 7523411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.
    Nishimichi N; Higashikawa F; Kinoh HH; Tateishi Y; Matsuda H; Yokosaki Y
    J Biol Chem; 2009 May; 284(22):14769-76. PubMed ID: 19346516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA; Agnihotri R; Vary CP; Liaw L
    Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5.
    Hu DD; Lin EC; Kovach NL; Hoyer JR; Smith JW
    J Biol Chem; 1995 Nov; 270(44):26232-8. PubMed ID: 7592829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the cryptic integrin-binding site in osteopontin suggests a new mechanism by which thrombin can regulate inflammation and tissue repair.
    Yokasaki Y; Sheppard D
    Trends Cardiovasc Med; 2000 May; 10(4):155-9. PubMed ID: 11239795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration.
    Ito K; Kon S; Nakayama Y; Kurotaki D; Saito Y; Kanayama M; Kimura C; Diao H; Morimoto J; Matsui Y; Uede T
    Matrix Biol; 2009 Jan; 28(1):11-9. PubMed ID: 19000758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin.
    Smith LL; Cheung HK; Ling LE; Chen J; Sheppard D; Pytela R; Giachelli CM
    J Biol Chem; 1996 Nov; 271(45):28485-91. PubMed ID: 8910476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C.
    Yokosaki Y; Matsuura N; Higashiyama S; Murakami I; Obara M; Yamakido M; Shigeto N; Chen J; Sheppard D
    J Biol Chem; 1998 May; 273(19):11423-8. PubMed ID: 9565552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin is a ligand for the alpha4beta1 integrin.
    Bayless KJ; Meininger GA; Scholtz JM; Davis GE
    J Cell Sci; 1998 May; 111 ( Pt 9)():1165-74. PubMed ID: 9547293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.
    Hu DD; Hoyer JR; Smith JW
    J Biol Chem; 1995 Apr; 270(17):9917-25. PubMed ID: 7537271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the alpha4beta1 integrin-osteopontin interaction.
    Barry ST; Ludbrook SB; Murrison E; Horgan CM
    Exp Cell Res; 2000 Aug; 258(2):342-51. PubMed ID: 10896785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.